Approval · Notice of Compliance 32238 · 2023
TRIDURAL: Notice of Compliance 32238
Issued December 1, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32238
- Date
- December 1, 2023
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the inner and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRIDURAL | Not yet assigned | — |
Medicinal ingredients
- TRAMADOL HCL 100 MG per TAB
- TRAMADOL HCL 200 MG per TAB
- TRAMADOL HCL 300 MG per TAB